About Mounjaro (Tirzepatide) in Ireland
Mounjaro is the brand name for tirzepatide, a groundbreaking once-weekly injectable medication originally developed to treat type 2 diabetes. In recent years, it has also been authorized in Europe for chronic weight management in adults with obesity or overweight who meet certain criteria:contentReference[oaicite:0]{index=0}:contentReference[oaicite:1]{index=1}. Mounjaro works by mimicking two natural gut hormones to regulate appetite and blood sugar, helping people feel fuller with less food. It’s a prescription-only medicine that, when combined with a healthy diet and exercise, can lead to dramatic weight loss results for eligible patients:contentReference[oaicite:2]{index=2}:contentReference[oaicite:3]{index=3}.
In Ireland, Mounjaro has quickly gained attention as a potent new option for weight loss. It is now available under medical supervision for adults with a high body mass index (BMI) or weight-related health issues, following its approval by the European authorities in 2024:contentReference[oaicite:4]{index=4}. This guide will explain what Mounjaro is, how it compares to other treatments like Ozempic® or Wegovy®, who can use it, how to access it in Ireland, the costs involved, dosing schedules, potential side effects, and the kind of results you might expect.
What Is Mounjaro and How Does It Work?
Mounjaro is an injectable medication containing tirzepatide, which is a first-in-class dual hormone receptor agonist. This means it activates two key hormones involved in blood sugar control and appetite: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide):contentReference[oaicite:5]{index=5}:contentReference[oaicite:6]{index=6}. By targeting both the GLP-1 and GIP receptors, tirzepatide helps to:
- Suppress appetite and cravings: It signals the brain to reduce hunger, helping you feel full sooner and for longer:contentReference[oaicite:7]{index=7}:contentReference[oaicite:8]{index=8}.
- Slow gastric emptying: It slows down how quickly your stomach empties after eating, prolonging fullness after meals:contentReference[oaicite:9]{index=9}:contentReference[oaicite:10]{index=10}.
- Improve metabolic control: Originally designed for diabetes, it increases insulin release and sensitivity when needed, keeping blood sugar levels stable:contentReference[oaicite:11]{index=11}:contentReference[oaicite:12]{index=12}. Steadier blood sugar may also aid weight management.
Through these dual actions, Mounjaro effectively helps reduce calorie intake and improve control over eating habits. In essence, it combines the benefits of GLP-1 agonist medications (like semaglutide in Ozempic/Wegovy) with the added action of GIP agonism for potentially greater effect:contentReference[oaicite:13]{index=13}:contentReference[oaicite:14]{index=14}. This unique mechanism is why many consider Mounjaro a significant advancement in weight loss treatment.
Mounjaro vs. Ozempic vs. Wegovy: How Does Tirzepatide Compare?
It’s natural to compare Mounjaro with other popular weight loss medications such as Ozempic and Wegovy, which contain semaglutide (a GLP-1 agonist). All of these are weekly injections that help with weight loss by curbing appetite, but there are key differences:
- Active Ingredient: Mounjaro’s active ingredient is tirzepatide, a dual GLP-1/GIP agonist, whereas Ozempic/Wegovy use semaglutide, a GLP-1 agonist only. Tirzepatide’s dual action may enhance its appetite-suppressing and metabolic effects:contentReference[oaicite:15]{index=15}:contentReference[oaicite:16]{index=16}.
- Weight Loss Efficacy: Clinical trials suggest Mounjaro can produce greater weight loss on average. Patients on the highest dose of tirzepatide (15 mg) lost around 21–22.5% of their body weight over ~72 weeks:contentReference[oaicite:17]{index=17}, whereas trials of semaglutide (Wegovy 2.4 mg) showed about 15% average weight loss in a similar period:contentReference[oaicite:18]{index=18}. In other words, Mounjaro has helped some patients lose even more weight than Wegovy in head-to-head comparisons:contentReference[oaicite:19]{index=19}. Every individual is different, but “up to 22%” body weight reduction has been cited for Mounjaro in studies:contentReference[oaicite:20]{index=20}.
- Treatment Indications: Wegovy (high-dose semaglutide) is approved specifically for weight management in obese or overweight patients, and Ozempic (lower-dose semaglutide) is officially for type 2 diabetes (often used off-label for weight loss). Mounjaro is approved in the EU for both indications – treating type 2 diabetes and, as of 2024, for weight loss in qualifying patients:contentReference[oaicite:21]{index=21}:contentReference[oaicite:22]{index=22}.
- Dosing and Administration: All three are weekly injections given under the skin (abdomen, thigh, or upper arm). Mounjaro is available in multiple dose strengths (2.5 mg up to 15 mg) titrated over time, whereas Wegovy comes in doses up to 2.4 mg weekly and Ozempic up to 1 mg (2 mg in some cases for diabetes). Mounjaro’s titration schedule is somewhat longer due to more dose levels (see dosing section below).
- Side Effect Profile: The types of side effects are similar (since both tirzepatide and semaglutide act on GLP-1 receptors). Nausea, stomach upset, etc., are common with all. Mounjaro’s dual action doesn’t drastically change side effect types, though some patients might experience certain GI symptoms differently. (See side effects section for details.)
In summary, Mounjaro (tirzepatide) offers an even more powerful option for weight loss compared to single-hormone GLP-1 medications. In practice, many patients who have struggled with or reached plateaus on Ozempic/Wegovy are interested in Mounjaro for its potentially greater weight reduction. That said, Wegovy and Ozempic are highly effective as well, and any of these medications should only be used if appropriate for your situation. A healthcare provider can help determine which option – if any – is best for you.
Who Is Eligible for Mounjaro in Ireland?
Eligibility: Mounjaro is generally prescribed for weight loss in adults who meet specific BMI criteria. In Ireland (consistent with EU approval), you may be eligible if:
- Your BMI is 30 or above (classified as obese), or
- Your BMI is 27 or above and you have at least one significant weight-related health condition (such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, etc.):contentReference[oaicite:23]{index=23}:contentReference[oaicite:24]{index=24}.
These criteria align with the approved indication for tirzepatide’s use in weight management. If you have type 2 diabetes with suboptimal control, you may also qualify for Mounjaro on that basis, as it is approved for diabetes treatment as well. Importantly, Mounjaro is intended for adults (18+ years), and it’s not used in children or during pregnancy/breastfeeding.
Suitability and Contraindications: Before starting Mounjaro, a medical professional will screen for any conditions that would make it unsafe. You should not use Mounjaro if you have a personal or family history of a rare thyroid cancer (MEDULLARY thyroid carcinoma) or a genetic endocrine tumor syndrome, as medications like tirzepatide and other GLP-1 agonists carry a precaution for these. Additionally, people with a history of pancreatitis are typically cautioned against using it, since GLP-1/GIP therapies may increase pancreatitis risk in susceptible individuals:contentReference[oaicite:25]{index=25}:contentReference[oaicite:26]{index=26}. If you have severe digestive tract problems or gallbladder disease, discuss this with your doctor as well. All of these factors will be evaluated during your consultation.
Medical Assessment: Obtaining Mounjaro in Ireland requires a prescription, which means a qualified doctor or prescribing pharmacist must evaluate you. They will review your weight, medical history, and overall health to ensure that:
- You meet the BMI and health criteria for treatment, and
- Mounjaro is medically appropriate and likely to be beneficial in your case.
This usually involves checking your recent weight/BMI, asking about past weight loss efforts, and making sure you don’t have any disqualifying conditions or medications. The consultation might be done in-person or through an online clinic.
How to Get a Mounjaro Prescription in Ireland
Doctor or Specialist: The traditional route is to speak with your GP or an obesity specialist. If they agree you meet the criteria and that tirzepatide is suitable, they can write a prescription. You would then take the prescription to a pharmacy that stocks Mounjaro. Not all local pharmacies may carry it initially, but many can order it upon request. Ireland’s health system currently does not subsidize Mounjaro for weight loss, so this would be a private prescription (you pay the pharmacy cost out-of-pocket).
Online Weight-Loss Clinics: Another convenient option is to use a regulated online service, such as Slimbr, which specializes in weight management. Slimbr offers access to Mounjaro through an online consultation with a licensed practitioner. You can start by taking a quick free online eligibility quiz to book a free assessment. In this assessment, a Slimbr clinician will review your health information (including BMI and any conditions) to determine if Mounjaro is appropriate for you. If you qualify, Slimbr’s medical team can provide a prescription for Mounjaro and guide you on obtaining the medication through a partner pharmacy.
**Slimbr Tip:** Slimbr’s service streamlines the process – you complete the assessment from home, and if approved, the prescription can be sent electronically to a pharmacy. This means you could avoid long wait times or multiple clinic visits. The initial quiz is free, and you’ll only proceed to paid steps if you’re eligible and choose to move forward.
Access and Availability: As of 2025, Mounjaro is available in Ireland, but supplies can be limited due to high demand globally. It’s advised to use a reliable pharmacy (or an online pharmacy if arranged by your provider) that can source the medication for you. Some Irish pharmacies (including online ones like Healthwave or Inish Pharmacy) list Mounjaro in various strengths. Always ensure you’re obtaining it from a reputable, licensed pharmacy – if using Slimbr or another service, they will typically connect you with a trusted pharmacy partner.
Mounjaro Dosage and Schedule
One key difference with Mounjaro (tirzepatide) is its dose escalation schedule. You do not start at the highest dose. Instead, the medication is introduced gradually to allow your body to adjust and to minimize side effects:contentReference[oaicite:27]{index=27}:contentReference[oaicite:28]{index=28}. The typical Mounjaro dosing schedule for weight loss is:
- Starting Dose – 2.5 mg: You’ll begin on 2.5 mg injected once weekly for the first 4 weeks:contentReference[oaicite:29]{index=29}:contentReference[oaicite:30]{index=30}. This is a low “getting used to it” dose and may not cause much weight loss; its main purpose is to let your body adapt.
- 5 mg Dose: After 4 weeks, if you’re tolerating it, the dose is usually increased to 5 mg once weekly. You’ll stay on 5 mg for at least another 4 weeks (weeks 5–8 of treatment):contentReference[oaicite:31]{index=31}.
- 7.5 mg Dose: Next, the dose can be raised to 7.5 mg weekly (typically in weeks 9–12) if needed for additional weight loss and if side effects are manageable:contentReference[oaicite:32]{index=32}.
- 10 mg Dose: Weeks 13–16, many patients move up to 10 mg weekly:contentReference[oaicite:33]{index=33}.
- 12.5 mg Dose: Weeks 17–20, dose may increase to 12.5 mg weekly:contentReference[oaicite:34]{index=34}.
- Maintenance – 15 mg: From week 21 onward, the target maximum dose is 15 mg once weekly:contentReference[oaicite:35]{index=35}. This is the highest dose of Mounjaro and the one that in trials led to the greatest average weight loss. Not everyone will need to go this high – some people achieve their goals or have more side effects at a lower dose and choose to stay at an intermediate dose.
This stepwise titration (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg) typically happens with at least 4 weeks on each level:contentReference[oaicite:36]{index=36}:contentReference[oaicite:37]{index=37}. Your healthcare provider will monitor your progress and side effects at each stage. If you’re doing well and still have weight to lose, they may advise continuing to increase. If you’re not tolerating a higher dose, it’s okay to stay longer at a lower dose or take extra time before the next increase. The goal is to find the dose that balances maximum weight loss with minimal side effects for you.
Administration: Mounjaro comes in a pre-filled “pen” injector for subcutaneous (under the skin) injection, similar to an insulin pen. You (or a trained person) will inject it once a week. It’s important to use it on the same day each week for consistency:contentReference[oaicite:38]{index=38}:contentReference[oaicite:39]{index=39}. The injection is relatively quick and is given in the abdomen, thigh, or upper arm (rotate sites to avoid irritation). Many patients find the injections easy to do after the first time – the pens are designed for patient self-use, with a tiny needle that you usually hardly feel.
Before injecting, always follow the instructions in the patient leaflet or those given by your healthcare provider. Store unused Mounjaro pens in the refrigerator (2–8°C) and don’t freeze them:contentReference[oaicite:40]{index=40}. When you’re ready to use a pen, you can take it out and let it reach room temperature for a few minutes, which can make injections more comfortable. Each pen is single-use (one dose) and should be disposed of in a sharps container after use:contentReference[oaicite:41]{index=41}.
What Results Can You Expect on Mounjaro?
Mounjaro has demonstrated remarkable results in weight loss trials and real-world use. However, individual outcomes will vary. Here’s an overview of the kind of weight loss results you might expect:
- Clinical Trial Averages: In a major trial (SURMOUNT-1) involving over 2,500 adults without diabetes, tirzepatide helped patients lose an average of about 15% of their starting body weight at the mid-range doses, and up to 22.5% of body weight on the highest 15 mg dose over 72 weeks:contentReference[oaicite:42]{index=42}. To put that in perspective, someone weighing 100 kg could lose 15–22 kg on average. Not everyone will hit those numbers, but it shows the potential.
- Majority Reach ≥5–10% Loss: Over 9 out of 10 patients on Mounjaro in that trial lost at least 5% of their weight, and about 8 out of 10 lost ≥10% of their weight by the end of ~1.5 years:contentReference[oaicite:43]{index=43}:contentReference[oaicite:44]{index=44}. Losing just 5–10% of body weight is often enough to significantly improve health markers (blood sugar, blood pressure, etc.), and Mounjaro enabled a very high proportion of patients to achieve this benchmark.
- Rapid Early Loss: Weight loss with Mounjaro tends to start quickly once you reach an effective dose. Many patients see noticeable changes after the first 2–3 months. In fact, studies noted around a 4% weight reduction in the first month on average:contentReference[oaicite:45]{index=45}:contentReference[oaicite:46]{index=46}. By 3 months (after titrating to ~7.5 mg), you might see roughly 8–10% body weight down in some cases:contentReference[oaicite:47]{index=47} – though it varies.
- One-Year Outcomes: Approaching the 1-year mark (about 52 weeks), clinical data and real-world reports often show 15% or more average body weight loss for those who stay on therapy and tolerate the higher doses:contentReference[oaicite:48]{index=48}:contentReference[oaicite:49]{index=49}. Some individuals lose even more (20%+), especially if they combine the medication with committed lifestyle changes, while others may lose less.
- Long-Term Weight Management: It’s important to note that medication is just one tool. The best results occur with concurrent improvements in diet and exercise. Mounjaro is meant to be part of a comprehensive plan. When the medication helps reduce appetite, it’s an opportunity to establish healthier eating patterns. Clinical trials required participants to follow a reduced-calorie diet and exercise regimen along with the injections:contentReference[oaicite:50]{index=50}. Those habits will help maintain weight loss if Mounjaro is ever stopped. If you discontinue Mounjaro but continue healthy lifestyle changes, you can help sustain your results; otherwise, some weight regain is possible once the drug’s effects wear off:contentReference[oaicite:51]{index=51}.
Beyond Weight Loss: Mounjaro’s benefits aren’t just about the number on the scale. Because tirzepatide was initially a diabetes medication, it can greatly improve blood sugar control. Even in people without diabetes, this can translate to better insulin sensitivity and metabolic health. Patients on Mounjaro have also seen improvements in blood pressure and cholesterol levels as they lose weight:contentReference[oaicite:52]{index=52}. There’s even evidence it can improve conditions like fatty liver disease and sleep apnea in obese patients:contentReference[oaicite:53]{index=53}:contentReference[oaicite:54]{index=54}. Many patients report NSVs (“non-scale victories”) such as increased energy, better sleep, reduced joint pain, and improved confidence as they shed weight.
Overall, Mounjaro is considered a highly effective weight loss therapy. It has, in clinical comparisons, outperformed older options like Saxenda (liraglutide daily injections) which produce ~5–7% weight loss, and even edged out semaglutide (Wegovy). Keep in mind, though, that weight loss is a journey – results take time and consistency. In the first month you might lose a few kilograms; by six months, possibly 10–15% of your weight; and by a year or more, potentially 20% or more if all goes well:contentReference[oaicite:55]{index=55}. Your healthcare team will monitor your progress and can suggest adjustments if weight loss plateaus (for example, ensuring the dose is optimal or incorporating additional nutritional guidance).
Potential Side Effects of Mounjaro
Like any medication, Mounjaro can cause side effects. Most side effects are related to its effects on the digestive system (which is how it helps cause weight loss). The good news is that for many people these effects are manageable and tend to improve over time as your body adapts:contentReference[oaicite:56]{index=56}. Common Mounjaro side effects include:
- Nausea – Feeling queasy is the most frequently reported side effect, especially when first starting or when upping the dose. About 1 in 5 people may experience some nausea:contentReference[oaicite:57]{index=57}. Eating smaller meals and bland foods can help, and it usually eases as weeks go by.
- Digestive upset – You might have episodes of vomiting, diarrhea, or stomach cramping, especially during dose increases:contentReference[oaicite:58]{index=58}:contentReference[oaicite:59]{index=59}. These were reported in a minority of patients (for example, vomiting and constipation in up to ~10%):contentReference[oaicite:60]{index=60}. Staying hydrated and avoiding greasy overeating can mitigate issues. Over-the-counter remedies (like anti-nausea or anti-diarrheal meds) may be used if advised by your doctor.
- Constipation – Some people experience slower bowel movements or constipation instead of diarrhea:contentReference[oaicite:61]{index=61}:contentReference[oaicite:62]{index=62}. This can be managed with high-fiber foods, plenty of water, and possibly mild laxatives if needed.
- Indigestion and Acid Reflux – Feeling of indigestion or heartburn can occur due to slower gastric emptying:contentReference[oaicite:63]{index=63}. Eating smaller, frequent meals and avoiding lying down right after eating can help. Your provider might recommend antacids or acid reducers if this becomes bothersome.
- Loss of appetite – This is an intended effect for weight loss, but it can be so pronounced that some people have to remind themselves to eat enough nourishing food. If you have diabetes, carefully monitor your blood sugar to avoid lows due to eating much less. Make sure to still get balanced nutrition even if you’re not as hungry:contentReference[oaicite:64]{index=64}.
- Fatigue or dizziness – Some patients feel a bit tired or lightheaded, especially if they’re eating far fewer calories. This usually improves as the body adjusts, but listen to your body and ensure you’re not over-restricting your diet.
- Injection site reactions – As with any shot, you could get slight redness, itching, or tenderness at the injection site:contentReference[oaicite:65]{index=65}. Rotating injection sites each week (abdomen, thigh, arm) prevents skin irritation in one spot. These reactions are typically mild and transient.
Most side effects with Mounjaro are classified as mild to moderate in severity and tend to occur more often during the initial dose or when the dose is increased:contentReference[oaicite:66]{index=66}. This is exactly why the dosing is gradual – to give your system time to adjust and minimize these effects:contentReference[oaicite:67]{index=67}:contentReference[oaicite:68]{index=68}. In practice, many people feel a bit of nausea or digestive change for a few days after a dose increase, then it fades. By the time you move to the next dose up, you might feel a return of mild nausea which again subsides. If any side effect is persistent or troublesome, definitely inform your healthcare provider. They might recommend supportive treatments (for example, prescribing an anti-nausea medication) or adjusting your dose timing.
Serious Side Effects: Serious adverse reactions on Mounjaro are rare. However, you should be aware of warning signs. In very uncommon cases, pancreatitis (inflammation of the pancreas) can occur with medications like this. Seek medical attention if you have severe abdominal pain that won’t go away (especially if it radiates to your back):contentReference[oaicite:69]{index=69}, as this could signal pancreatitis or gallbladder issues. Also, if you experience symptoms like persistent vomiting or signs of dehydration (which can happen if you can’t keep liquids down), let a doctor know. A small number of people in trials had to stop Mounjaro due to side effects (~3%:contentReference[oaicite:70]{index=70}, meaning the vast majority could continue).
It’s reassuring that in clinical studies and now real-world use, Mounjaro’s safety profile has been quite good – it was “shown to be safe and effective for long-term use” when monitored properly:contentReference[oaicite:71]{index=71}. The European Medicines Agency concluded that its benefits outweigh the risks for approved patients:contentReference[oaicite:72]{index=72}. Just make sure you’re under medical supervision throughout your weight loss journey. Routine check-ins (either via Slimbr’s platform or with your GP) are important to track progress, address side effects, and check things like your blood sugar or other relevant labs if needed.
Mounjaro Price in Ireland – How Much Does It Cost?
Weight loss injections like Mounjaro are unfortunately quite expensive, as they are brand-name biopharmaceuticals without generic alternatives yet. In Ireland, the cost of Mounjaro depends on the dose strength you are using. Pharmacies typically price it per pre-filled pen (each pen contains one month’s worth of weekly doses at a given strength). As of 2025, approximate prices for a month’s supply of Mounjaro from Irish pharmacies are in the range of:
- €275–€300 for the 2.5 mg starter dose (four 2.5 mg pens):contentReference[oaicite:73]{index=73}:contentReference[oaicite:74]{index=74},
- €350–€375 for 5 mg (four 5 mg pens):contentReference[oaicite:75]{index=75},
- €450–€480 for 7.5 mg or 10 mg (per month):contentReference[oaicite:76]{index=76}, and
- €570–€600 for the higher doses 12.5 mg or 15 mg (per month):contentReference[oaicite:77]{index=77}.
In other words, as your dose increases, the monthly medication cost rises, roughly ranging from ~€275 at the low end up to ~€600 at the high end. The above figures are based on data compiled from multiple Irish pharmacies (including online sources) in late 2024 – actual prices may vary slightly by pharmacy and over time. For example, one large online pharmacy (Healthwave) lists 2.5 mg at €275, 5 mg at €360, 7.5 mg at €475, and 15 mg at €595:contentReference[oaicite:78]{index=78}:contentReference[oaicite:79]{index=79}. Inish Pharmacy’s pricing is in a similar ballpark (e.g. ~€289 for 2.5 mg, €350 for 5 mg, €465 for 7.5 mg):contentReference[oaicite:80]{index=80}. It’s a significant financial commitment, and unfortunately insurance or the public health service (HSE) does not currently cover Mounjaro for weight loss. It is not on the Drugs Payment Scheme or medical card reimbursement list as of now:contentReference[oaicite:81]{index=81}, so patients must bear the full cost out-of-pocket.
Besides the medication itself, keep in mind any consultation fees for the prescribing service. For instance, if you go through Slimbr, the initial quiz is free, but you may pay a consultation fee once you proceed with a clinician (Slimbr’s site often offers an upfront cost that covers the medical review and prescription if you’re approved). Traditional private clinics or GPs may charge for the consultation as well. These fees can range from around €20 (for some online doctor services) up to €100+ for private specialist visits. Slimbr’s model is to make this affordable and transparent – at the time of writing, Slimbr consultations start from around €**109 (check Slimbr for current pricing), which includes the prescriber review and ongoing support, but note you still pay the pharmacy for the medication separately.
It’s worth noting that due to high demand, there have been periodic shortages or backorders of weight-loss injections globally. Prices can fluctuate, and some patients opt to compare pharmacy prices. However, be cautious: you should only obtain Mounjaro through legitimate pharmacies with a valid prescription. Do not trust any offers to buy it without a prescription or from unofficial sources (which could be scams or counterfeit products). Slimbr or your doctor will guide you to get the medicine safely and legally.
Conclusion: Is Mounjaro Right for You?
Mounjaro (tirzepatide) represents an exciting advancement in obesity treatment – offering hope of significant weight loss to those who have struggled with traditional methods alone. In Ireland, many people are already seeing life-changing results with this medication, losing not just pounds but also improving their overall health. That said, it’s not a magic wand or a quick fix; it requires commitment to a healthier lifestyle and careful medical oversight.
If you have a high BMI or weight-related health issues and are researching options, Mounjaro could be a game-changer. It has shown the ability to help patients lose 20% or more of their weight in clinical studies:contentReference[oaicite:82]{index=82}, far above what older therapies achieved. The dual-action approach of tirzepatide sets it apart from other GLP-1 drugs like Ozempic/Wegovy, and for many individuals it can break through weight loss plateaus. However, you’ll need to consider the cost, the need for weekly injections, and potential side effects. It’s also a long-term treatment – experts often recommend staying on these medications to maintain the weight loss, similar to how we treat other chronic conditions.
Next Steps: The first step is to find out if you’re a candidate. If you’re interested in Mounjaro, talk to your doctor or take Slimbr’s free online assessment quiz to evaluate your eligibility. Slimbr’s weight-loss professionals can then guide you through a personalized plan, answer any questions, and, if appropriate, prescribe Mounjaro for you without delay. With the proper support and monitoring, you can safely harness this medication to achieve meaningful weight loss and health improvements.
Remember, successful weight management is a journey – Mounjaro is one powerful tool on that journey, and with the right guidance, it may help you reach a healthier weight and a better quality of life. If you’re ready to take the next step, start with a free Slimbr consultation and see if Mounjaro is the right solution for you. Here’s to your health and success!



